09/06/2015

ESTEVE RECEIVES ASPID AWARD FOR TRIPTOMAX

The Triptomax communication campaign has been awarded a silver ASPID in the category of Integrated Advertising. These Ibero-American Health and Pharmacy awards are granted every year to the best advertising works in Spain.

ESTEVE's Triptomax is a dietary supplement that helps naturally restore a positive mood. Its advertising campaign, consisting of TV commercials, external and in-store ads, and merchandising, has been awarded a silver ASPID in the 19th edition of these awards, held at the World Trade Center of Barcelona.

The Triptomax campaign targets people aged 35 to 55 years who are active but feel overwhelmed by different circumstances. Unlike the advertising of other multivitamin products, which address the problem or the need, this campaign focuses on the benefit provided by this product: seeing and living life in a positive way.

The Ibero-American Health and Pharmacy ASPID Awards are convened every year by the magazine PMFarma in collaboration with the Sepromark Marketing Club, and acknowledge the creativity in advertising pharmaceutical products and the communication of services related to health and healthcare.


You can follow ESTEVE on Twitter at this link: twitter.com/esteve_news.

Last news

  • ESTEVE APPOINTS JORDI MUNTAÑOLA AS CHIEF COMMERCIAL OFFICER FOR EUROPE

    Jordi Muntañola will take on the leadership of all the pharmaceutical activities in Spain and Europe

    read more
  • POMPEU FABRA UNIVERSITY AND ESTEVE ARE TO INVESTIGATE NEW TARGETS FOR TREATING NEUROPATHIC PAIN

    The RIBOPAIN project aims to identify new therapeutic solutions for pain and to develop more effective drugs

    read more
  • ESTEVE ANNOUNCES A RESTRUCTURING OF ITS PHARMACEUTICAL ACTIVITY

    Esteve Pharmaceuticals submits a reduction in force (RIF) which will affect 103 jobs in Spain

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.